Interleukin 7 and sCD23 Synergize in the Induction of Human T Cell Activation in HIV-1-Infected Subjects

International Archives of Allergy and Immunology

Volumn 114, Issue 2, 1997, Pages 120-129

  Fratazzi, Candida ^a   Guerriero, Mirella ^b   Carini, Claudio ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Ospedale Civile di Latina   (Italy)

Author keywords

Cytotoxic; HIV 1; IFN ; Interleukin 7; Soluble CD23; T cells; T lymphocytes

Indexed keywords

CD23 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 7;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030827985     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237656     Document Type: Article

References (49)

1. Spickett GP. Dalglcish AG: Cellular immunology oflllV-1 infection. Clin Exp Med 1988:71: 1-6.
2. Odcrmatt U. Eppler M. Leitz TP. Hengartncr H. Zinkemagel RM: Virus triggered acquired immunodeficiency by cytotoxic T cell dependent destruction of antigen presenting cells and lymph follicle structure. Proc Natl Acad Sci USA 1991;88:8252-8258.
3. Phillips RE. Roland-Johns S. Nixon DF. McMi-ehael AJ: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991:354:453-456.
4. Takaashi H, Nakagavva Y, Pendleton CD, Peters J, Siegel T: Induction of broadly cross-reactive cytotoxic T cells recognizing an IIIV-I-I envelope determinant. Science 1992:255:333-337.
5. McMichael AJ. Walker BD: Cytotoxic T lymphocyte epitopes: Implication for FI IV vaccines. AIDS 1994:1:155-161.
6. Kou i RA, Safrit JT, Coa Y, Andrews A, McLeod G, Bokowsky W, Farthing C, FIO DD: Temporal association of cellular immune response with initial control of viremia in primary human immunodeficiency virus type I syndrome. J Virol 1994:68:4650-4656.
7. Borrow PH. Lcwicki BM. Hahn G. Shaw GM. Oldstonc MBA: Virus specific CDS+ cytotoxic T lymphocyte activity associated with control of viremia in primary HIV infection. J Virol 1994:68:6103-6112.
8. Carmichael A. Jin X. Sissons P. Borvsicwicz L: Quantitative analysis of the 11IV-1 specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential C'TL responses to HIV-1 and EBV in late disease. J Exp Med 1991;177:249-261.
9. Klein MR. Van Baakcn A: Kinetics of gag specific cytotoxic T lymphocyte response during the clinical course of HIV infection: A longitudinal analysis of rapid progression and longterm progression. J Exp Med 1995:181:1356-1366.
10. Gillis S, Smith KA: Longterm culture of tumor specific cytotoxic T cells. Nature 1977:268: 154-156.
11. Rvser JE, Cerottini JC, Brunner KT: Generation of cytotoxic T lymphocytes in vitro. IX. Induction of secondary CTL responses in primary long-term MLC by supernatants from second-ary MLC. J Immunol 1978;120:370-377.
12. Erard F, Cothesy P, Nabholz M, Eiscn J: Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Immunol 1985:134:1644-1652.
13. Chen LK, Tourvielle B, Bums CF, Bach FH. Mathieu-Mahul D. Sasportes M. Bezoussan A: Interferon: A cytotoxic T lymphocyte differentiation signa. EurJ Immunol 1986:16:767-775.
14. Siegel JP: Effects of interferon gamma on the activation of human T lymphocytes. Cell Immunol 1988:111:461-472.
15. Horohov DV, Lrim AJ, Smith PA, Siegel JP: 1L4 regulates multiple aspects of influenza vims specific cell mediated immunity. J Immunol 1988:141:4217-4224.
16. Widmcr MB. Grabstcin KH: Regulation of cytolytic T lymphocyte generation by B cell stimulatory factor. Nature 1987:326:795-798.
17. Takai YG. Wong G. Clark SC. Burakoff SJ. I lermmann SH: B cell stimulatory factor 2 is involved in the differentiation of cytotoxic T lymphocyte. J Immunol 1988:140:508-513.
18. Osato G. Pike SE: Interferon beta 2/Interleukin 6 is a costimulant for human T lymphocytes. J Immunol 1988; 141: 1556-1564.
19. Mchrotra PT. Wu J. Crim JA. Mostowsky IIW. Siegel JP: Effects of IL 12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol 1993:151:2444-2451.
20. Clately MK. Wolitzky AG. Quinn PM. Chizo-nite R: Regulation of human cytolytic lymphocyte responses by interleukin 12. Cell Immunol 1992:143:127-134.
21. Bloom ET. Ilorvath JA: Cellular and molecular mechanisms of the IL12 induced increase in al-lospccific murine cytolytic T cell activity. J Immunol 1994; 152:4242-4251.
22. Morrissey PJ, Goodwin RG, Nordan RP: Recombinant IL-7, pre-B cell growth factor, has co-stimulatory activity on purified mature T cells. J Exp Med 1989;169:707-712.
23. Mongomery RA, Dallman MJ: Analysis of cytokine gene expression during fetal thymic ontogeny using PCR. J Immunol 1991:147:554-561.
24. Goodwin RG, Lupton S, Schmierer A, Hierrild KJ, Jery R, Clevanger W, Gillis S, Cosman D, Namen AE: Human interleukin 7: Molecular cloning and growth factor activity on human and murine B lineage cells. Proc Natl Acad Sci USA 1989:86:302-309.
25. Carini C, Essex ME: Interleukin 2 independent IL-7 activity enhances cytotoxic immune response of HIV-1-I infected individuals. AIDS Res Hum Retroviruses 1994; 10:121-129.
26. Carini C, McLane MF, Mayer KH, Essex M: Dysregulation of 1L-7R may generate loss of cytotoxic T cell response in HIV-1 -1 infection. EurJ Immunol 1994:24:2927-2934.
27. Carini C. Essex ME: Predominant V l usage in HIV-1 specific CTL with reduced IL-7 receptor expression; in Ginsberg GI I (ed): Vaccine 93. Cold Spring Harbor Symposia. Cold Spring I larbor, 1993, p 24.
28. Watanabe Y, Sudo T, Ohnishi A, Katsura K: Interleukin 7 preferentially supports the growth of yó T cell receptor bearing T cells from fetal thymocytes in vitro, hit Immunol 1991:3:1067.
29. Carini C. Fratazzi C: CD23 expression in activated human T cells is enhanced by interleukin7.hit Arch Allergy Immunol 1996:110:23-30.
30. Bonnefoy JY. Ilenchos S. Hardie D. Holder MJ. Gordon J: A subset of anti-CD21 antibodies promote the rescue of germinal centerBcells from apoptosis. EurJ Immunol 1993:23:969-975.
31. Carini C, Margolick J, Yodoi J, Lshizaka K: Formation of IgE binding factors by T cells of patients infected with human immunodeficiency virus type I. Proc Natl Acad Sci USA 1988:85: 9214-9218.
32. I lober D. Ajana F. Boniface M. Estrada R. Robert P. Sartiauz C, Mouton Y, Wattre P, Montreuil M: Soluble CD23 in human immunodeficiency virus type 1 infected patients. Microbiol Immunol 1993;37:383-390.
33. Yametz S, Cumberland WG, Van der Meydon M. Martincz-Maza O: Elevated serum levels of sCD23 precede the appearance of acquired immunodeficiency syndrome associated non-Hodgkin’s lymphoma. Blood 1995;85:1843-1849.
34. Wright DN, Nelson R, Ledford D, Fcrnandez-Caldes E, Trudeau W, Lockey R: Serum IgE and human immunodeficiency virus (HIV-1) infection. J Allergy Clin Immunol 1990;32:445-451.
35. Kawabe T, Maekawa N, Maeda Y, Hosoda M, Yodoi J: Induction of FcsRII/CD23 on phytohemagglutinin activated human peripheral blood T lymphocytes.JImmunol 1991;147:548-554.
36. Carini C, Pini C, Difelice G, Fattorossi A, Fratazzi C: CD23 IcrRII expression on phytohe-magglutinin-A or phorbolmyristate acctctatc Ca activated human tonsil T cells. Int Arch Allergy Immunol 1993; 101:31-38.
37. Chazen GD. Pereira GMB. Legros G. Gillis S. Shevach EM: Interleukin 7 is a T cell growth factor. Proc Natl Acad Sei USA 1989:86:5923-5930.
38. Earl PL, Koenig ES, Moss B: Biological and immunological properties of human immunodeficiency virus type I envelope glycoprotein: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J Virol 1991:65:31-38.
39. Grabstein KH, Namen AE, Shanebeck K, Voice FR, Reed SG, Widemer MB: Regulation of T cell proliferation by IL-7. J Immunol 1990:144: 3015-3021.
40. Armant M. Rubio M. Delespesse G. Sarfati M: Soluble CD23 directly activates monocytes to contribute to the antigen independent stimulation of resting T cells. J Immunol 1995:155: 4868-4874.
41. Armant M., lshihara H, Rubio M, Delespesse G, Sarafati M: Regulation of cytokine production by soluble CD23: Costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release. J Exp Med 1994:180: 1005-1011.
42. Novelii F. Giovarelli M. Gentz R. Zucca M. Di-piciTo F. Garrota G. Forni i: Modulation of interferon y receptor during human T lymphocyte alloactivation. EurJ Immunol 1993:23:1226-1231.
43. Poli G, Fauci AS: Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-173.
44. Kovacs JA. Baseler M. Dewar RI. Vogel S. Da-vei RT. Falloon J. Polis MA. Walker RE. Stevens R. Salsman NP. Netcalf JA. Masur H. Lane HC: Increases in CD4 T lymphocytes with intermittent courses of IL-2 in patients with I IIV infection. N Engl J Med 1995;332:567-570.
45. Clerici M. Lucci DR. Berzovsky JA. Pinto LA. Wynn TA. Blatt SP. Dolan MJ. Andrix CW. Waif SF. Shearer GM: Restoration of HIV specific cell mediated immune responses by IL-12 in vitro. Science 1993:262:1721-1724.
46. Welch PA. Namen AE. Godwin RC. Armitage R. Cooper MD: Human IL7: A novel T cell growth factor. J Immunol 1989:143:3562-3569.
47. Fratazzi C. Carini C: Expression of CD23 and release of IgEBF in HIV infected T cell lines. ENT Immunol 1989;2:34-41.
48. Alderson MRT, Zcgler SF, Grabstein KII: Interleukin 7 induces cytokine secretion and tumor-icidal activity by human peripheral blood monocytes. J Exp Med 1991:173:923-931.
49. Horohov DW. Stocks NE. Siegel JP: Limiting dilution analysis of human CTL differentiation. Requirement fora lymphokine mediated differentiation signal. Immunology 1988:65:119-124.